Invention Grant
- Patent Title: Globin gene therapy for treating hemoglobinopathies
-
Application No.: US15449416Application Date: 2017-03-03
-
Publication No.: US11717579B2Publication Date: 2023-08-08
- Inventor: Michel Sadelain , Isabelle Riviere , Jorge Mansilla-Soto , Xiuyan Wang , George Stamatoyannopoulos , John Stamatoyannopoulos , Mingdong Liu
- Applicant: MEMORIAL SLOAN-KETTERING CANCER CENTER , UNIVERSITY OF WASHINGTON
- Applicant Address: US NY New York
- Assignee: MEMORIAL SLOAN-KETTERING CANCER CENTER,UNIVERSITY OF WASHINGTON
- Current Assignee: MEMORIAL SLOAN-KETTERING CANCER CENTER,UNIVERSITY OF WASHINGTON
- Current Assignee Address: US NY New York; US WA Seattle
- Agency: Baker Botts L.L.P.
- Main IPC: C12N15/86
- IPC: C12N15/86 ; C12N15/63 ; A61K48/00 ; C12N15/11 ; C07K14/805 ; C12N9/22 ; C12N15/85

Abstract:
The presently disclosed subject matter provides for expression cassettes that allow for expression of a globin gene or a functional portion thereof, vectors comprising thereof, and cells transduced with such expression cassettes and vectors. The presently disclosed subject matter further provides methods for treating a hemoglobinopathy in a subject comprising administering an effective amount of such transduced cells to the subject.
Public/Granted literature
- US20170173185A1 GLOBIN GENE THERAPY FOR TREATING HEMOGLOBINOPATHIES Public/Granted day:2017-06-22
Information query
IPC分类: